Evidence map›Paper›PMID 37292914›Full record

ArticlebioRxiv : the preprint server for biology2023

Viral modulation of type II interferon increases T cell adhesion and virus spread.

Carina Jürgens, George Ssebyatika, Sarah Beyer, Nina Plückebaum, Kai A Kropp, Víctor González-Motos, Birgit Ritter, Heike Böning, Eirini Nikolouli, Paul R Kinchington and 4 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Carina JürgensInstitute of Virology, Hannover Medical School, Hannover 30625, Germany.
George SsebyatikaInstitute of Virology, Hannover Medical School, Hannover 30625, Germany.
Sarah BeyerInstitute of Virology, Hannover Medical School, Hannover 30625, Germany.
Nina PlückebaumInstitute of Virology, Hannover Medical School, Hannover 30625, Germany.
Kai A KroppInstitute of Virology, Hannover Medical School, Hannover 30625, Germany.
Víctor González-MotosInstitute of Virology, Hannover Medical School, Hannover 30625, Germany.
Birgit RitterInstitute of Virology, Hannover Medical School, Hannover 30625, Germany.
Heike BöningInstitute of Virology, Hannover Medical School, Hannover 30625, Germany.
Eirini NikolouliDepartment for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover 30625, Germany.
Paul R KinchingtonDepartment of Ophthalmology and of Molecular Microbiology and Genetics, University of Pittsburgh, Pittsburgh, PA, United States.
Nico LachmannDepartment for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover 30625, Germany.
Daniel Pearce DepledgeInstitute of Virology, Hannover Medical School, Hannover 30625, Germany.
Thomas KreyInstitute of Virology, Hannover Medical School, Hannover 30625, Germany.
Abel Viejo-BorbollaInstitute of Virology, Hannover Medical School, Hannover 30625, Germany.
Medizinische Hochschule Hannover · DEUniversity of Pittsburgh · USUniversity of Veterinary Medicine Hannover, Foundation · DE

Funding

Virus Production and Manipulation of Protein/Gene Expression ModuleP30EY008098 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Yuanyuan Chen · 1989 to 2026
$17.8M
VZV vaccine attenuation and the DNA damage responseR01AI158510 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Paul R. Kinchington · 2022 to 2026
$3.2M
NEI NIH HHS P30 EY008098NIAID NIH HHS R01 AI158510
6 · The paper itself

Abstract

During primary infection, varicella zoster virus (VZV) infects epithelial cells in the respiratory lymphoid organs and mucosa. Subsequent infection of lymphocytes, T cells in particular, causes primary viremia allowing systemic spread throughout the host, including the skin. This results in the expression of cytokines, including interferons (IFNs) which partly limit primary infection. VZV also spreads from skin keratinocytes to lymphocytes prior to secondary viremia. How VZV infects lymphocytes from epithelial cells while evading the cytokine response has not been fully established. Here, we show that VZV glycoprotein C (gC) binds IFN-γ and modifies its activity. Transcriptomic analysis revealed that gC in combination with IFN-γ increased the expression of a small subset of IFN-stimulated genes (ISGs), including intercellular adhesion molecule 1 (

Indexed as

biased signalingICAM1immunomodulationInterferon gammaLFA-1T cell adhesionvaricella zoster virusvirus spread

Identifiers

PMID37292914
PMCPMC10246016
OpenAlexW4378532833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.